South Korea · Delayed Price · Currency is KRW SD Biosensor Statistics
Total Valuation
SD Biosensor has a market cap or net worth of KRW 1.13 trillion. The enterprise value is 987.96 billion.
| Market Cap | 1.13T |
| Enterprise Value | 987.96B |
Important Dates
The last earnings date was Friday, November 7, 2025.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
SD Biosensor has 119.62 million shares outstanding. The number of shares has decreased by -1.64% in one year.
| Current Share Class | 119.62M |
| Shares Outstanding | 119.62M |
| Shares Change (YoY) | -1.64% |
| Shares Change (QoQ) | +0.56% |
| Owned by Insiders (%) | 32.20% |
| Owned by Institutions (%) | 2.66% |
| Float | 32.40M |
Valuation Ratios
The trailing PE ratio is 10.02.
| PE Ratio | 10.02 |
| Forward PE | n/a |
| PS Ratio | 1.62 |
| PB Ratio | 0.37 |
| P/TBV Ratio | 1.01 |
| P/FCF Ratio | 4.76 |
| P/OCF Ratio | 3.81 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.97, with an EV/FCF ratio of 4.17.
| EV / Earnings | 8.73 |
| EV / Sales | 1.42 |
| EV / EBITDA | 13.97 |
| EV / EBIT | n/a |
| EV / FCF | 4.17 |
Financial Position
The company has a current ratio of 7.50, with a Debt / Equity ratio of 0.21.
| Current Ratio | 7.50 |
| Quick Ratio | 5.51 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | 8.94 |
| Debt / FCF | 2.66 |
| Interest Coverage | -0.99 |
Financial Efficiency
Return on equity (ROE) is 3.75% and return on invested capital (ROIC) is -1.20%.
| Return on Equity (ROE) | 3.75% |
| Return on Assets (ROA) | -1.10% |
| Return on Invested Capital (ROIC) | -1.20% |
| Return on Capital Employed (ROCE) | -1.79% |
| Revenue Per Employee | 1.21B |
| Profits Per Employee | 196.55M |
| Employee Count | 576 |
| Asset Turnover | 0.18 |
| Inventory Turnover | 1.58 |
Taxes
| Income Tax | -366.17B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.50% in the last 52 weeks. The beta is 0.84, so SD Biosensor's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | -15.50% |
| 50-Day Moving Average | 9,689.60 |
| 200-Day Moving Average | 10,050.10 |
| Relative Strength Index (RSI) | 49.10 |
| Average Volume (20 Days) | 118,494 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SD Biosensor had revenue of KRW 696.13 billion and earned 113.22 billion in profits. Earnings per share was 941.16.
| Revenue | 696.13B |
| Gross Profit | 336.86B |
| Operating Income | -68.35B |
| Pretax Income | -253.92B |
| Net Income | 113.22B |
| EBITDA | 70.49B |
| EBIT | -68.35B |
| Earnings Per Share (EPS) | 941.16 |
Balance Sheet
The company has 778.10 billion in cash and 630.14 billion in debt, giving a net cash position of 147.96 billion or 1,236.89 per share.
| Cash & Cash Equivalents | 778.10B |
| Total Debt | 630.14B |
| Net Cash | 147.96B |
| Net Cash Per Share | 1,236.89 |
| Equity (Book Value) | 3.07T |
| Book Value Per Share | 25,505.86 |
| Working Capital | 1.06T |
Cash Flow
In the last 12 months, operating cash flow was 295.74 billion and capital expenditures -58.93 billion, giving a free cash flow of 236.81 billion.
| Operating Cash Flow | 295.74B |
| Capital Expenditures | -58.93B |
| Free Cash Flow | 236.81B |
| FCF Per Share | 1,979.73 |
Margins
Gross margin is 48.39%, with operating and profit margins of -9.82% and 16.26%.
| Gross Margin | 48.39% |
| Operating Margin | -9.82% |
| Pretax Margin | -36.48% |
| Profit Margin | 16.26% |
| EBITDA Margin | 10.13% |
| EBIT Margin | -9.82% |
| FCF Margin | 34.02% |
Dividends & Yields
This stock pays an annual dividend of 200.00, which amounts to a dividend yield of 2.12%.
| Dividend Per Share | 200.00 |
| Dividend Yield | 2.12% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 21.35% |
| Buyback Yield | 1.64% |
| Shareholder Yield | 3.78% |
| Earnings Yield | 10.04% |
| FCF Yield | 20.99% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SD Biosensor has an Altman Z-Score of 2.01 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.01 |
| Piotroski F-Score | 6 |